Solventum SOLV
NYSE SOLV
$89.57 +0.96 (+1.08%)
At close: Aug 21, 2026 · 4:00 PM EDT

Solventum (SOLV) Cash from Investing Activities (2023 - 2026)

Solventum's (SOLV) quarterly Cash from Investing Activities came in at -$77.0 million in Q1 2026, up 32.46% YoY from -$58.1 million in Q1 2025, and up 89.66% on a QoQ basis from -$745.0 million in Q4 2025.

Solventum (SOLV) Cash from Investing Activities (2023 - 2026) Analysis & Trends

Solventum (SOLV) has 4 years of Cash from Investing Activities data on file, last reported at -$77.0 million in Q1 2026.

  • Quarterly Cash from Investing Activities rose 32.46% year-over-year to -$77.0 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $2.8 billion (up 822.96% YoY) and the FY2025 annual result came in at $2.8 billion, up 836.05% from the prior year.
  • Cash from Investing Activities advanced to -$77.0 million in Q1 2026, from -$745.0 million in the prior quarter.
  • In the past five years, Cash from Investing Activities ranged from a high of $3.8 billion in Q3 2025 to a low of -$745.0 million in Q4 2025.
  • A 4-year average of $162.3 million and a median of -$88.0 million in 2023 frame the typical range for Cash from Investing Activities.
  • Annual changes were most pronounced in 2024 — Cash from Investing Activities tumbled 1450.0% — and 2025, when it jumped 4149.46%.
  • Tracing SOLV's Cash from Investing Activities over 4 years: stood at -$88.0 million in 2023, then sank by 44.32% to -$127.0 million in 2024, then plunged by 486.61% to -$745.0 million in 2025, then soared by 89.66% to -$77.0 million in 2026.
  • The last three Cash from Investing Activities figures came in at -$77.0 million (Q1 2026), -$745.0 million (Q4 2025), and $3.8 billion (Q3 2025), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Cash from Investing Activities (Qtr)
1 Intuitive Surgical 134.13 Bn 128.91 Bn 1.96 Bn -26.60 Mn
2 Becton Dickinson 52.76 Bn 51.90 Bn 2.32 Bn -241.00 Mn
3 Alcon 35.81 Bn 34.46 Bn 1.68 Bn -222.00 Mn
4 Resmed 33.72 Bn 32.25 Bn 861.22 Mn -383.65 Mn
5 Medline 29.38 Bn 26.70 Bn 2.22 Bn -461.00 Mn
6 West Pharmaceutical Services 25.00 Bn 24.57 Bn 329.20 Mn -43.20 Mn
7 Solventum 15.46 Bn 15.06 Bn 1.29 Bn -87.00 Mn
8 Cooper Companies 14.88 Bn 14.74 Bn 735.40 Mn -90.00 Mn
9 Baxter International 13.58 Bn 11.43 Bn 1.03 Bn -117.00 Mn
10 Align Technology 11.61 Bn 10.51 Bn 757.43 Mn -82.16 Mn

Historic Data

Download Data
DateValue
Jun 30, 2026 -87.00 Mn
Jun 30, 2026 -87.00 Mn
Mar 31, 2026 -77.00 Mn
Mar 31, 2026 -77.00 Mn
Dec 31, 2025 -745.00 Mn
Dec 31, 2025 -745.00 Mn
Sep 30, 2025 3.77 Bn
Sep 30, 2025 3.77 Bn
Jun 30, 2025 -110.00 Mn
Jun 30, 2025 -110.00 Mn
Mar 31, 2025 -114.00 Mn
Mar 31, 2025 -114.00 Mn
Dec 31, 2024 -127.00 Mn
Dec 31, 2024 -127.00 Mn
Sep 30, 2024 -93.00 Mn
Sep 30, 2024 -93.00 Mn
Jun 30, 2024 -58.00 Mn
Jun 30, 2024 -58.00 Mn
Mar 31, 2024 -102.00 Mn
Mar 31, 2024 -102.00 Mn